Sequence of echocardiographic changes during development of right ventricular failure in rat

被引:82
作者
Hardziyenka, Maxim
Campian, Maria E.
de Bruin-Bon, Rianne
Michel, Martin C.
Tan, Hanno L.
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Clin & Expt Cardiol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Pharmacol & Pharmacotherapy, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1016/j.echo.2006.04.036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The temporal relations between the onset of echocardiographic changes and clinical diagnosis of right ventricular (RV) failure are unresolved. We have characterized such relations in a rat monocrotaline (MCT) model of RV failure. Methods: Eight-week-old male Wistar rats were injected with MCT (60 mg/kg) or vehicle and underwent serial echocardiography. RV free-wall thickness (RVWT), pulmonary artery acceleration time normalized to cycle length (PAAT/CL), RV end-diastolic diameter (RVEDD), and tricuspid annular plane systolic excursion (TAPSE) were measured. Results: Significant differences in echocardiographic parameters between MCT-treated and control rats were found as early as 14 days before RV failure for RVWT, 10 days for PAAT/CL, and 7 days for RVEDD and TAPSE. The time intervals between the onset of changes in RVWT, PAAT/CL, RVEDD, and TAPSE and diagnosis of RV failure were 11.3 +/- 0.8, 10.9 +/- 0.7, 6.5 +/- 0.5, and 5.4 +/- 0.7 days, respectively. The sequence of echocardiographic changes was consistent in all animals during development of RV failure. Conclusions. Pulmonary hypertension (assessed by PAAT/CL) and RV free-wall thickening (characterized by RVWT) precede RV dilation and RV systolic dysfunction (measured by RVEDD and TAPSE, respectively). Echocardiographic analysis permits accurate determination of the stage of disease development in MCT-induced RV failure.
引用
收藏
页码:1272 / 1279
页数:8
相关论文
共 34 条
[1]   Heart failure in the adult patient with congenital heart disease [J].
Book, WM .
JOURNAL OF CARDIAC FAILURE, 2005, 11 (04) :306-312
[2]   Pulmonary arterial hypertension - The key role of echocardiography [J].
Bossone, E ;
Bodini, BD ;
Mazza, A ;
Allegra, L .
CHEST, 2005, 127 (05) :1836-1843
[3]   Cardiac endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat [J].
Brunner, F .
CARDIOVASCULAR RESEARCH, 1999, 44 (01) :197-206
[4]   Hypothermia is a bedside predictor of imminent death in patients with congestive heart failure [J].
Casscells, W ;
Vasseghi, MF ;
Siadaty, MS ;
Madjid, M ;
Siddiqui, H ;
Lal, B ;
Payvar, S .
AMERICAN HEART JOURNAL, 2005, 149 (05) :927-933
[5]   NORADRENALINE, ATRIAL NATRIURETIC PEPTIDE, BOMBESIN AND NEUROTENSIN IN MYOCARDIUM AND BLOOD OF RATS IN CONGESTIVE CARDIAC-FAILURE [J].
CECONI, C ;
CONDORELLI, E ;
QUINZANINI, M ;
RODELLA, A ;
FERRARI, R ;
HARRIS, P .
CARDIOVASCULAR RESEARCH, 1989, 23 (08) :674-682
[6]   Haemodynamic evaluation of pulmonary hypertension [J].
Chemla, D ;
Castelain, V ;
Hervé, P ;
Lecarpentier, Y ;
Brimioulle, S .
EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (05) :1314-1331
[7]   Rat models of hypertension, cardiac hypertrophy and failure [J].
Doggrell, SA ;
Brown, L .
CARDIOVASCULAR RESEARCH, 1998, 39 (01) :89-105
[8]   Effect of nolomirole on monocrotaline-induced heart failure [J].
Evasio, P ;
Anna, C ;
Fiorella, P ;
Roberta, R ;
Stefano, B ;
Luca, GG ;
Roberto, F .
PHARMACOLOGICAL RESEARCH, 2004, 49 (01) :1-5
[9]   TWO-DIMENSIONAL AND DOPPLER-ECHOCARDIOGRAPHIC AND CARDIAC-CATHETERIZATION CORRELATES OF SURVIVAL IN PRIMARY PULMONARY-HYPERTENSION [J].
EYSMANN, SB ;
PALEVSKY, HI ;
REICHEK, N ;
HACKNEY, K ;
DOUGLAS, PS .
CIRCULATION, 1989, 80 (02) :353-360
[10]  
Farahmand F, 2004, MOL CELL BIOCHEM, V260, P21